ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
ABEONA THERAPEUTICS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$4.41−0.02 (-0.45%)
Close on Oct 19, 2026
- Market cap
- $251.58M
- P/E (TTM)
- –
- Dividend yield
- –
ABEONA THERAPEUTICS INC. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q2 25 | Q3 20 | Q2 19 | Q1 19 | Q4 18 | Q3 18 | Q2 18 | Q1 18 | Q4 17 | Q3 17 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $11.38M | $8.72M | – | – | – | – | – | – | – | – | – | – | 100.0% | – |
| Foundation revenues | – | – | – | – | $0 | $0 | $369.00K | $1.69M | $259.00K | $481.00K | $0 | $0 | – | – |
| Royalties [Member] | – | – | – | – | $0 | $0 | $113.00K | $22.00K | $17.00K | $50.00K | $65.00K | $68.00K | – | – |
| License [Member] | – | – | $400.00K | $7.00M | – | – | $0 | $0 | $0 | $0 | $150.00K | $151.00K | – | – |
| Foundation Revenues [Member] | – | – | – | – | – | – | $369.00K | $1.69M | $259.00K | $481.00K | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Abeona Therapeutics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.